Rankings
▼
Calendar
SCLX FY 2020 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena
SCLX
Scilex Holding Company
$72M
FY 2020 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$24M
+12.0% YoY
Gross Profit
$21M
90.9% margin
Operating Income
-$35M
-149.7% margin
Net Income
-$48M
-201.7% margin
EPS (Diluted)
$-0.01
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$31M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$82M
Total Liabilities
$223M
Stockholders' Equity
-$142M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$21M
+12.0%
Gross Profit
$21M
$15M
+40.6%
Operating Income
-$35M
-$139M
+74.6%
Net Income
-$48M
-$179M
+73.4%
← Q4 2019
All Quarters
Q1 2020 →